$209.17
-0.84-0.40%
At close: -
$209.25
0.080.04%
After Hours: 5:44 PM EDT
Comments
Loading...
AbbVie Stock Guidance | NYSE:ABBV | Benzinga
AbbVie issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/31/2025 | ABBV | AbbVie | FY | 2025 | $12.12 | $12.32 | $12.13 | — | — | — | Get Alert |
| 01/06/2025 | ABBV | AbbVie | FY | 2024 | $10.02 | $10.06 | $10.94 | — | — | — | Get Alert |
| 01/06/2025 | ABBV | AbbVie | Q4 | 2024 | $2.06 | $2.10 | $2.98 | — | — | — | Get Alert |
| 10/30/2024 | ABBV | AbbVie | Q4 | 2024 | $2.94 | $2.98 | $2.95 | $14.80B | $14.80B | $14.64B | Get Alert |
| 10/30/2024 | ABBV | AbbVie | FY | 2024 | $10.90 | $10.94 | $10.85 | — | — | — | Get Alert |
| 10/03/2024 | ABBV | AbbVie | FY | 2024 | $10.71 | $10.91 | $10.88 | — | — | — | Get Alert |
| 10/03/2024 | ABBV | AbbVie | Q3 | 2024 | $2.92 | $2.96 | $2.95 | — | — | — | Get Alert |
| 08/01/2024 | ABBV | AbbVie | FY | 2024 | $10.71 | $10.91 | $10.87 | — | — | — | Get Alert |
| 08/01/2024 | ABBV | AbbVie | Q3 | 2024 | $2.92 | $2.96 | $2.94 | — | — | — | Get Alert |
| 07/25/2024 | ABBV | AbbVie | FY | 2024 | $10.71 | $10.91 | $9.93 | $55.50B | $55.50B | $55.34B | Get Alert |
| 07/25/2024 | ABBV | AbbVie | Q3 | 2024 | $2.92 | $2.96 | $2.91 | $14.20B | $14.20B | $14.22B | Get Alert |
| 07/03/2024 | ABBV | AbbVie | FY | 2024 | $10.61 | $10.81 | $11.25 | — | — | — | Get Alert |
| 07/03/2024 | ABBV | AbbVie | Q2 | 2024 | $2.53 | $2.57 | $3.05 | — | — | — | Get Alert |
| 04/26/2024 | ABBV | AbbVie | FY | 2024 | $11.13 | $11.33 | $11.10 | $55.00B | $55.00B | $54.60B | Get Alert |
| 04/26/2024 | ABBV | AbbVie | Q2 | 2024 | $3.05 | $3.09 | $2.81 | $14.00B | $14.00B | $13.57B | Get Alert |
| 04/03/2024 | ABBV | AbbVie | Q1 | 2024 | $2.18 | $2.22 | $2.33 | — | — | — | Get Alert |
| 04/03/2024 | ABBV | AbbVie | FY | 2024 | $10.97 | $11.17 | $11.19 | — | — | — | Get Alert |
| 02/12/2024 | ABBV | AbbVie | FY | 2024 | $11.05 | $11.25 | $11.18 | — | — | — | Get Alert |
| 02/12/2024 | ABBV | AbbVie | Q1 | 2024 | $2.26 | $2.30 | $2.39 | — | — | — | Get Alert |
| 02/02/2024 | ABBV | AbbVie | Q1 | 2024 | $2.30 | $2.34 | $2.31 | $11.90B | $11.90B | $11.37B | Get Alert |
| 02/02/2024 | ABBV | AbbVie | FY | 2024 | $11.05 | $11.25 | $11.24 | $54.20B | $54.20B | $49.94B | Get Alert |
| 01/05/2024 | ABBV | AbbVie | FY | 2023 | $11.04 | $11.08 | $11.22 | — | — | — | Get Alert |
| 01/05/2024 | ABBV | AbbVie | Q4 | 2023 | $2.72 | $2.76 | $2.90 | — | — | — | Get Alert |
| 10/27/2023 | ABBV | AbbVie | FY | 2023 | $11.19 | $11.23 | $10.42 | — | — | — | Get Alert |
| 10/27/2023 | ABBV | AbbVie | FY | 2024 | $11.00 | $11.00 | $10.45 | — | — | — | Get Alert |
| 10/04/2023 | ABBV | AbbVie | FY | 2023 | $10.86 | $11.06 | $11.07 | — | — | — | Get Alert |
| 10/04/2023 | ABBV | AbbVie | Q3 | 2023 | $2.76 | $2.86 | $2.88 | — | — | — | Get Alert |
| 07/27/2023 | ABBV | AbbVie | Q3 | 2023 | $2.80 | $2.90 | $2.82 | $13.70B | $13.70B | $13.35B | Get Alert |
| 07/27/2023 | ABBV | AbbVie | FY | 2023 | $10.90 | $11.10 | $10.87 | — | — | — | Get Alert |
| 07/06/2023 | ABBV | AbbVie | FY | 2023 | $10.57 | $10.97 | $10.08 | — | — | — | Get Alert |
| 07/06/2023 | ABBV | AbbVie | Q2 | 2023 | $2.75 | $2.85 | $2.69 | — | — | — | Get Alert |
| 04/27/2023 | ABBV | AbbVie | Q2 | 2023 | $2.90 | $3.00 | $2.85 | $13.50B | $13.50B | $13.36B | Get Alert |
| 04/27/2023 | ABBV | AbbVie | FY | 2023 | $10.72 | $11.12 | $10.94 | — | — | — | Get Alert |
| 04/05/2023 | ABBV | AbbVie | FY | 2023 | $10.62 | $11.02 | $11.07 | — | — | — | Get Alert |
| 04/05/2023 | ABBV | AbbVie | Q1 | 2023 | $2.31 | $2.41 | $2.55 | — | — | — | Get Alert |
| 02/09/2023 | ABBV | AbbVie | Q1 | 2023 | $2.39 | $2.49 | $3.08 | $11.80B | $11.80B | $13.36B | Get Alert |
| 02/09/2023 | ABBV | AbbVie | FY | 2024 | $10.70 | — | — | — | — | — | Get Alert |
| 02/09/2023 | ABBV | AbbVie | FY | 2023 | $10.70 | $11.10 | $11.65 | $52.00B | $52.00B | $54.21B | Get Alert |
| 01/06/2023 | ABBV | AbbVie | FY | 2022 | $13.70 | $13.74 | $13.85 | — | — | — | Get Alert |
| 01/06/2023 | ABBV | AbbVie | Q4 | 2022 | $3.51 | $3.55 | $3.67 | — | — | — | Get Alert |
| 10/28/2022 | ABBV | AbbVie | FY | 2022 | $13.84 | $13.88 | $13.86 | $58.20B | $58.20B | $58.92B | Get Alert |
| 10/28/2022 | ABBV | AbbVie | Q4 | 2022 | $3.65 | $3.69 | $3.75 | $15.20B | $15.20B | $15.78B | Get Alert |
| 10/05/2022 | ABBV | AbbVie | FY | 2022 | $13.76 | $13.96 | $13.87 | — | — | — | Get Alert |
| 10/05/2022 | ABBV | AbbVie | Q3 | 2022 | $3.53 | $3.57 | $3.60 | — | — | — | Get Alert |
| 07/29/2022 | ABBV | AbbVie | Q3 | 2022 | $3.55 | $3.59 | $3.67 | $14.80B | $14.80B | $15.28B | Get Alert |
| 07/29/2022 | ABBV | AbbVie | FY | 2022 | $13.78 | $13.98 | $13.91 | $58.90B | $58.90B | $59.59B | Get Alert |
| 07/06/2022 | ABBV | AbbVie | Q2 | 2022 | $3.24 | $3.28 | $3.43 | — | — | — | Get Alert |
| 07/06/2022 | ABBV | AbbVie | FY | 2022 | $13.78 | $13.98 | $14.01 | — | — | — | Get Alert |
| 04/29/2022 | ABBV | AbbVie | Q2 | 2022 | $3.38 | $3.42 | $3.47 | $14.60B | $14.60B | $14.77B | Get Alert |
| 04/29/2022 | ABBV | AbbVie | FY | 2022 | $13.92 | $14.12 | $14.11 | $59.40B | $59.40B | $60.04B | Get Alert |
| 02/02/2022 | ABBV | AbbVie | FY | 2022 | $14.00 | $14.20 | $13.99 | — | — | — | Get Alert |
| 10/29/2021 | ABBV | AbbVie | FY | 2021 | $12.63 | $12.67 | $12.59 | $56.20B | $56.20B | $56.28B | Get Alert |
| 10/29/2021 | ABBV | AbbVie | Q4 | 2021 | $3.24 | $3.28 | $3.30 | $15.00B | $15.00B | $15.01B | Get Alert |
| 07/30/2021 | ABBV | AbbVie | FY | 2021 | $12.52 | $12.62 | $12.60 | — | — | — | Get Alert |
| 04/30/2021 | ABBV | AbbVie | Q2 | 2021 | $3.05 | $3.09 | $3.06 | $13.60B | $13.60B | $13.52B | Get Alert |
| 04/30/2021 | ABBV | AbbVie | FY | 2021 | $12.37 | $12.57 | $12.45 | $55.90B | $55.90B | $55.34B | Get Alert |
| 02/03/2021 | ABBV | AbbVie | FY | 2021 | $12.32 | $12.52 | $12.18 | — | — | — | Get Alert |
| 10/30/2020 | ABBV | AbbVie | Q4 | 2020 | $2.83 | $2.85 | $2.90 | $13.80B | $13.80B | $13.69B | Get Alert |
| 10/30/2020 | ABBV | AbbVie | FY | 2020 | $10.47 | $10.49 | $10.42 | $45.70B | $45.70B | $45.49B | Get Alert |
| 07/31/2020 | ABBV | AbbVie | FY | 2020 | $10.35 | $10.45 | $10.32 | — | — | — | Get Alert |
FAQ
What is the most recent guidance for AbbVie (ABBV)?
The most recent guidance for AbbVie (ABBV) was reported on January 31, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $12.12 to $12.32, compared to the estimated EPS of $12.13. Additionally, AbbVie forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.